Introduction
Under Development
MyoScore is currently under active development and not yet publicly available.
MyoScore (Genetic Muscle Health Score, GMHS) is a transcriptome-based quantitative assessment system for muscle health.
Overview
GMHS integrates GWAS-TWAS analysis with multi-cohort RNA-seq data to construct an objective myopathy severity score. It quantifies muscle health on a 0-100 scale across five genetically-driven dimensions.
Five Dimensions
| Dimension | Weight | GWAS Source | Meaning |
|---|---|---|---|
| Strength | 25.2% | Grip strength, walking pace | Muscle function |
| Mass | 17.7% | Fat-free mass (whole body, appendicular) | Muscle mass |
| LeanMuscle | 24.3% | Thigh fat infiltration MRI | Low fat = healthy |
| Youth | 24.2% | Telomere length | Biological age |
| Resilience | 8.7% | Myopathy diagnosis, CK levels | Disease resistance |
Score interpretation: Higher score = Healthier muscle
Citation
Revealing myopathy spectrum: integrating transcriptional and clinical features of human skeletal muscles with varying health conditions. Communications Biology, 2024.